BMC Neurology has published the results of the HYPNOS I clinical trial demonstrating the sedative action of the Cefaly medical device (http://www.ncbi.nlm.nih.gov/pubmed/22035386).
The results show, in a statistically highly significant manner using four clinical measurement methods, a pronounced reduction in vigilance induced by the action of the Cefaly(R) Hypnos medical device, by comparison to a placebo.
This sedative action on the central nervous system is observed after application for 12 minutes in 83% of individuals whose mean increase in tiredness was of 73%.